Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Diagnosis and Treatment of Female Pattern Hair Loss

Description

The presentation discusses female pattern hair loss, emphasizing its diagnosis and treatment strategies. It highlights that this condition can emerge in two life stages: post-puberty and later during perimenopause. Key diagnostic features include patterns of hair density loss, particularly the frontal accentuation pattern. The speaker notes that miniaturization of hair follicles is a primary factor in this type of hair loss, which is generally classified as non-scarring despite the potential for follicular loss over time. Various treatment options are outlined, including minoxidil, which may have androgenic effects. Comparisons between oral and topical forms of minoxidil are discussed, along with dosage considerations and potential side effects. Other treatments mentioned include spironolactone, bicalutamide, and 5-alpha reductase inhibitors like finasteride and dutasteride, while also addressing their implications for women of childbearing potential. Adjunct therapies such as low-level laser therapy, microneedling, and platelet-rich plasma (PRP) therapy are explored for their efficacy in enhancing hair growth. The speaker concludes by urging a more proactive approach in treating female pattern hair loss to prevent irreversible follicular damage, advocating for a combination of treatments to optimize outcomes.

View more

Conclusions

  • Female pattern hair loss (FPHL) is a progressive condition with the potential for end-stage follicular loss if untreated.
  • Early intervention in FPHL may prevent irreversible follicular dropout.
  • Current treatments for FPHL aim to reduce the effect of androgens on susceptible hair follicles using antiandrogens and 5-alpha reductase inhibitors.
  • Minoxidil, both topical and oral, serves as a growth stimulant for hair in affected individuals.
  • Light and laser therapies can promote hair growth by stimulating affected follicles.
  • Anti-inflammatory medications may target microbial factors in the follicular infundibulum that contribute to hair loss.
  • Combination therapy considering both efficacy and potential side effects appears to be the best approach for treating FPHL.
  • Olsen A. (2005)
  • Whiting D. (Year unspecified)
  • Sinclair R et al. (2011) BJD 165:12-18
  • Ramos et al. (2020) JAAD
  • Kincaid (2024)
  • Rozner (2019)
  • Piraccini (Year unspecified)
  • Avram M. (2024) Abstracts. Lasers Surg Med, 56: S148-S149
  • Lee (Year unspecified)
  • Liu et al. (Year unspecified) Laser in Med Science